Key result
Novel cholesterol polygenic score strongly predicts hypercholesterolemia but is not associated with Alzheimer's disease risk.
Cohort
Yes
Answers are grounded in this paper and cite their sources.
Midlife hypercholesterolemia is a well-known risk factor for sporadic Alzheimer’s disease (AD), and like AD, it is highly influenced by genetics with heritability estimates of 32–63%. We thus hypothesized that genetics underlying peripheral blood total cholesterol (TC) levels could influence the risk of developing AD. We created a weighted polygenic score (TC-PGS) using summary data from a meta-analysis of TC genome-wide association studies for evaluation in three independent AD-related cohorts spanning pre-clinical, clinical, and pathophysiologically proved AD. APOE-ε4 variant was purposely included in the analysis as it represents an already well-established genetic risk factor for both AD and circulating TC. We could vastly improve the performance of the score when considering p-value thresholds for inclusion in the score, sex, and statin use. This optimized score (p-value threshold of 1 × 10−6 for inclusion in the score) explained 18.2% of the variance in TC levels in statin free females compared to 6.9% in the entire sample and improved prediction of hypercholesterolemia (receiver operator characteristics analysis revealed area under the curve increase from 70.8% to 80.5%). The TC-PGS was further evaluated for association with AD risk and pathology. We found no association between the TC-PGS and either of the AD hallmark pathologies, assessed by cerebrospinal fluid levels of Aβ-42, p-Tau, and t-Tau, and 18F-NAV4694 and 18F-AV-1451 positron emission tomography. Similarly, we found no association with the risk of developing amyloid pathology or becoming cognitively impaired in individuals with amyloid pathology.
No takes yet. Share an insight, caveat, or question.
Nilsson et al. (2021) conducted a cohort in Alzheimer's disease and hypercholesterolemia. Total cholesterol polygenic score (TC-PGS) was evaluated on Variance in total cholesterol levels, hypercholesterolemia prediction, and association with Alzheimer's disease hallmark pathologies (CSF Aβ-42, p-Tau, t-Tau, PET imaging) and risk. An optimized total cholesterol polygenic score explained 18.2% of cholesterol variance in statin-free females but was not associated with AD pathology or risk.
Synapse has enriched 10 related papers. Consider them for comparative context: